TALENGEN INSTITUTE OF LIFE SCIENCES, CO., LTD.;深圳瑞健生命科學研究院有限公司
发明人:
李季男
申请号：
HK18116717
公开号：
HK1257598A1
申请日:
2018.12.28
申请国别(地区):
HK
年份:
2019
代理人:
摘要：
The invention relates to a method for preventing or treating myocardial injury of subjects. The method comprises the steps of giving the effective amount of plasminogen to the subjects who have myocardial injury risk, suspected myocardial injury or affected myocardial injury. The invention also relates to a medicine, a pharmaceutical composition, a product and a kit containing the plasminogen forpreventing or treating the myocardial injury of the subjects.
